Medicine

An op-ed by Jason Karlawish of the Perelman School of Medicine is quoted encouraging a system of “whealthcare” that integrates monitoring and maintaining mental health and wealth, to foster older adults’ financial well-being.

David Oslin of the Perelman School of Medicine discusses the implications of his latest research examining whether genetic testing can be used to help prescribe antidepressants.

Joel Mainland of the Perelman School of Medicine and colleagues have used a neural network to create a molecular map of odors in compounds that repel mosquitos.

Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for their key 2005 advances with synthetic mRNA.

Alums Mindy and Jon Gray are funding the Basser Institute for Cancer Interception to focus on early detection and prevention of breast, ovarian, pancreatic, and prostate cancers.

Mindy and Jon Gray’s new Basser Institute is a spinoff of their previously funded Basser Center for BRCA, named for Mindy’s late sister Faith Basser and led by Susan Domchek of the Perelman School of Medicine.

Aimee Payne of the Perelman School of Medicine says that the University of Erlangen-Nürnberg’s new CAR-T therapy lupus research represents a landmark study in the treatment of autoimmunity.

Capstan Therapeutics, a Penn spinout whose founders include Carl June, Bruce Levine, and Drew Weissman of the Perelman School of Medicine, has launched with $165 million raised to develop a new type of CAR therapy that incorporates mRNA.

Karen Lasater of the School of Nursing says that most hospitals try to subsist on thin margins of staffing, which for nurses results in worse results for patients and eroded trust in their employers.

Stuart Isaacs of the Perelman School of Medicine evaluates the decline in new cases of monkeypox and speaks on what factors to examine in the virus’s future trajectory.